Global Ibandronate Market Growth (Status and Outlook) 2023-2029

March 2023 | 89 pages | ID: G1481E72FFFEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Ibandronate is prescription medication used for treating osteoporosis in women after menopause.

LPI (LP Information)' newest research report, the “Ibandronate Industry Forecast” looks at past sales and reviews total world Ibandronate sales in 2022, providing a comprehensive analysis by region and market sector of projected Ibandronate sales for 2023 through 2029. With Ibandronate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ibandronate industry.

This Insight Report provides a comprehensive analysis of the global Ibandronate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ibandronate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ibandronate market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ibandronate and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ibandronate.

The global Ibandronate market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Ibandronate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Ibandronate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Ibandronate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Ibandronate players cover Roche, Apotex, Mylan, Sun Pharmaceutical, Dr Reddy's Laboratories, Aurobindo Pharma and MACLEODS, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Ibandronate market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• Oral
• Injection

Segmentation by application

• Hospital
• Drug store

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Roche
• Apotex
• Mylan
• Sun Pharmaceutical
• Dr Reddy's Laboratories
• Aurobindo Pharma
• MACLEODS

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Ibandronate Market Size 2018-2029
  2.1.2 Ibandronate Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Ibandronate Segment by Type
  2.2.1 Oral
  2.2.2 Injection
2.3 Ibandronate Market Size by Type
  2.3.1 Ibandronate Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Ibandronate Market Size Market Share by Type (2018-2023)
2.4 Ibandronate Segment by Application
  2.4.1 Hospital
  2.4.2 Drug store
2.5 Ibandronate Market Size by Application
  2.5.1 Ibandronate Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Ibandronate Market Size Market Share by Application (2018-2023)

3 IBANDRONATE MARKET SIZE BY PLAYER

3.1 Ibandronate Market Size Market Share by Players
  3.1.1 Global Ibandronate Revenue by Players (2018-2023)
  3.1.2 Global Ibandronate Revenue Market Share by Players (2018-2023)
3.2 Global Ibandronate Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 IBANDRONATE BY REGIONS

4.1 Ibandronate Market Size by Regions (2018-2023)
4.2 Americas Ibandronate Market Size Growth (2018-2023)
4.3 APAC Ibandronate Market Size Growth (2018-2023)
4.4 Europe Ibandronate Market Size Growth (2018-2023)
4.5 Middle East & Africa Ibandronate Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Ibandronate Market Size by Country (2018-2023)
5.2 Americas Ibandronate Market Size by Type (2018-2023)
5.3 Americas Ibandronate Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Ibandronate Market Size by Region (2018-2023)
6.2 APAC Ibandronate Market Size by Type (2018-2023)
6.3 APAC Ibandronate Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Ibandronate by Country (2018-2023)
7.2 Europe Ibandronate Market Size by Type (2018-2023)
7.3 Europe Ibandronate Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Ibandronate by Region (2018-2023)
8.2 Middle East & Africa Ibandronate Market Size by Type (2018-2023)
8.3 Middle East & Africa Ibandronate Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL IBANDRONATE MARKET FORECAST

10.1 Global Ibandronate Forecast by Regions (2024-2029)
  10.1.1 Global Ibandronate Forecast by Regions (2024-2029)
  10.1.2 Americas Ibandronate Forecast
  10.1.3 APAC Ibandronate Forecast
  10.1.4 Europe Ibandronate Forecast
  10.1.5 Middle East & Africa Ibandronate Forecast
10.2 Americas Ibandronate Forecast by Country (2024-2029)
  10.2.1 United States Ibandronate Market Forecast
  10.2.2 Canada Ibandronate Market Forecast
  10.2.3 Mexico Ibandronate Market Forecast
  10.2.4 Brazil Ibandronate Market Forecast
10.3 APAC Ibandronate Forecast by Region (2024-2029)
  10.3.1 China Ibandronate Market Forecast
  10.3.2 Japan Ibandronate Market Forecast
  10.3.3 Korea Ibandronate Market Forecast
  10.3.4 Southeast Asia Ibandronate Market Forecast
  10.3.5 India Ibandronate Market Forecast
  10.3.6 Australia Ibandronate Market Forecast
10.4 Europe Ibandronate Forecast by Country (2024-2029)
  10.4.1 Germany Ibandronate Market Forecast
  10.4.2 France Ibandronate Market Forecast
  10.4.3 UK Ibandronate Market Forecast
  10.4.4 Italy Ibandronate Market Forecast
  10.4.5 Russia Ibandronate Market Forecast
10.5 Middle East & Africa Ibandronate Forecast by Region (2024-2029)
  10.5.1 Egypt Ibandronate Market Forecast
  10.5.2 South Africa Ibandronate Market Forecast
  10.5.3 Israel Ibandronate Market Forecast
  10.5.4 Turkey Ibandronate Market Forecast
  10.5.5 GCC Countries Ibandronate Market Forecast
10.6 Global Ibandronate Forecast by Type (2024-2029)
10.7 Global Ibandronate Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Roche
  11.1.1 Roche Company Information
  11.1.2 Roche Ibandronate Product Offered
  11.1.3 Roche Ibandronate Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Roche Main Business Overview
  11.1.5 Roche Latest Developments
11.2 Apotex
  11.2.1 Apotex Company Information
  11.2.2 Apotex Ibandronate Product Offered
  11.2.3 Apotex Ibandronate Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Apotex Main Business Overview
  11.2.5 Apotex Latest Developments
11.3 Mylan
  11.3.1 Mylan Company Information
  11.3.2 Mylan Ibandronate Product Offered
  11.3.3 Mylan Ibandronate Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Mylan Main Business Overview
  11.3.5 Mylan Latest Developments
11.4 Sun Pharmaceutical
  11.4.1 Sun Pharmaceutical Company Information
  11.4.2 Sun Pharmaceutical Ibandronate Product Offered
  11.4.3 Sun Pharmaceutical Ibandronate Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Sun Pharmaceutical Main Business Overview
  11.4.5 Sun Pharmaceutical Latest Developments
11.5 Dr Reddy's Laboratories
  11.5.1 Dr Reddy's Laboratories Company Information
  11.5.2 Dr Reddy's Laboratories Ibandronate Product Offered
  11.5.3 Dr Reddy's Laboratories Ibandronate Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Dr Reddy's Laboratories Main Business Overview
  11.5.5 Dr Reddy's Laboratories Latest Developments
11.6 Aurobindo Pharma
  11.6.1 Aurobindo Pharma Company Information
  11.6.2 Aurobindo Pharma Ibandronate Product Offered
  11.6.3 Aurobindo Pharma Ibandronate Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Aurobindo Pharma Main Business Overview
  11.6.5 Aurobindo Pharma Latest Developments
11.7 MACLEODS
  11.7.1 MACLEODS Company Information
  11.7.2 MACLEODS Ibandronate Product Offered
  11.7.3 MACLEODS Ibandronate Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 MACLEODS Main Business Overview
  11.7.5 MACLEODS Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Ibandronate Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Injection
Table 4. Ibandronate Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Ibandronate Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Ibandronate Market Size Market Share by Type (2018-2023)
Table 7. Ibandronate Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Ibandronate Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Ibandronate Market Size Market Share by Application (2018-2023)
Table 10. Global Ibandronate Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Ibandronate Revenue Market Share by Player (2018-2023)
Table 12. Ibandronate Key Players Head office and Products Offered
Table 13. Ibandronate Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Ibandronate Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Ibandronate Market Size Market Share by Regions (2018-2023)
Table 18. Global Ibandronate Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Ibandronate Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Ibandronate Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Ibandronate Market Size Market Share by Country (2018-2023)
Table 22. Americas Ibandronate Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Ibandronate Market Size Market Share by Type (2018-2023)
Table 24. Americas Ibandronate Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Ibandronate Market Size Market Share by Application (2018-2023)
Table 26. APAC Ibandronate Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Ibandronate Market Size Market Share by Region (2018-2023)
Table 28. APAC Ibandronate Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Ibandronate Market Size Market Share by Type (2018-2023)
Table 30. APAC Ibandronate Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Ibandronate Market Size Market Share by Application (2018-2023)
Table 32. Europe Ibandronate Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Ibandronate Market Size Market Share by Country (2018-2023)
Table 34. Europe Ibandronate Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Ibandronate Market Size Market Share by Type (2018-2023)
Table 36. Europe Ibandronate Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Ibandronate Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Ibandronate Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Ibandronate Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Ibandronate Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Ibandronate Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Ibandronate Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Ibandronate Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Ibandronate
Table 45. Key Market Challenges & Risks of Ibandronate
Table 46. Key Industry Trends of Ibandronate
Table 47. Global Ibandronate Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Ibandronate Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Ibandronate Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Ibandronate Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Roche Details, Company Type, Ibandronate Area Served and Its Competitors
Table 52. Roche Ibandronate Product Offered
Table 53. Roche Ibandronate Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Roche Main Business
Table 55. Roche Latest Developments
Table 56. Apotex Details, Company Type, Ibandronate Area Served and Its Competitors
Table 57. Apotex Ibandronate Product Offered
Table 58. Apotex Main Business
Table 59. Apotex Ibandronate Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Apotex Latest Developments
Table 61. Mylan Details, Company Type, Ibandronate Area Served and Its Competitors
Table 62. Mylan Ibandronate Product Offered
Table 63. Mylan Main Business
Table 64. Mylan Ibandronate Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Mylan Latest Developments
Table 66. Sun Pharmaceutical Details, Company Type, Ibandronate Area Served and Its Competitors
Table 67. Sun Pharmaceutical Ibandronate Product Offered
Table 68. Sun Pharmaceutical Main Business
Table 69. Sun Pharmaceutical Ibandronate Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Sun Pharmaceutical Latest Developments
Table 71. Dr Reddy's Laboratories Details, Company Type, Ibandronate Area Served and Its Competitors
Table 72. Dr Reddy's Laboratories Ibandronate Product Offered
Table 73. Dr Reddy's Laboratories Main Business
Table 74. Dr Reddy's Laboratories Ibandronate Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Dr Reddy's Laboratories Latest Developments
Table 76. Aurobindo Pharma Details, Company Type, Ibandronate Area Served and Its Competitors
Table 77. Aurobindo Pharma Ibandronate Product Offered
Table 78. Aurobindo Pharma Main Business
Table 79. Aurobindo Pharma Ibandronate Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Aurobindo Pharma Latest Developments
Table 81. MACLEODS Details, Company Type, Ibandronate Area Served and Its Competitors
Table 82. MACLEODS Ibandronate Product Offered
Table 83. MACLEODS Main Business
Table 84. MACLEODS Ibandronate Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. MACLEODS Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Ibandronate Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Ibandronate Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Ibandronate Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Ibandronate Sales Market Share by Country/Region (2022)
Figure 8. Ibandronate Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Ibandronate Market Size Market Share by Type in 2022
Figure 10. Ibandronate in Hospital
Figure 11. Global Ibandronate Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Ibandronate in Drug store
Figure 13. Global Ibandronate Market: Drug store (2018-2023) & ($ Millions)
Figure 14. Global Ibandronate Market Size Market Share by Application in 2022
Figure 15. Global Ibandronate Revenue Market Share by Player in 2022
Figure 16. Global Ibandronate Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Ibandronate Market Size 2018-2023 ($ Millions)
Figure 18. APAC Ibandronate Market Size 2018-2023 ($ Millions)
Figure 19. Europe Ibandronate Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Ibandronate Market Size 2018-2023 ($ Millions)
Figure 21. Americas Ibandronate Value Market Share by Country in 2022
Figure 22. United States Ibandronate Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Ibandronate Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Ibandronate Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Ibandronate Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Ibandronate Market Size Market Share by Region in 2022
Figure 27. APAC Ibandronate Market Size Market Share by Type in 2022
Figure 28. APAC Ibandronate Market Size Market Share by Application in 2022
Figure 29. China Ibandronate Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Ibandronate Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Ibandronate Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Ibandronate Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Ibandronate Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Ibandronate Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Ibandronate Market Size Market Share by Country in 2022
Figure 36. Europe Ibandronate Market Size Market Share by Type (2018-2023)
Figure 37. Europe Ibandronate Market Size Market Share by Application (2018-2023)
Figure 38. Germany Ibandronate Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Ibandronate Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Ibandronate Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Ibandronate Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Ibandronate Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Ibandronate Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Ibandronate Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Ibandronate Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Ibandronate Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Ibandronate Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Ibandronate Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Ibandronate Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Ibandronate Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Ibandronate Market Size 2024-2029 ($ Millions)
Figure 52. APAC Ibandronate Market Size 2024-2029 ($ Millions)
Figure 53. Europe Ibandronate Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Ibandronate Market Size 2024-2029 ($ Millions)
Figure 55. United States Ibandronate Market Size 2024-2029 ($ Millions)
Figure 56. Canada Ibandronate Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Ibandronate Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Ibandronate Market Size 2024-2029 ($ Millions)
Figure 59. China Ibandronate Market Size 2024-2029 ($ Millions)
Figure 60. Japan Ibandronate Market Size 2024-2029 ($ Millions)
Figure 61. Korea Ibandronate Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Ibandronate Market Size 2024-2029 ($ Millions)
Figure 63. India Ibandronate Market Size 2024-2029 ($ Millions)
Figure 64. Australia Ibandronate Market Size 2024-2029 ($ Millions)
Figure 65. Germany Ibandronate Market Size 2024-2029 ($ Millions)
Figure 66. France Ibandronate Market Size 2024-2029 ($ Millions)
Figure 67. UK Ibandronate Market Size 2024-2029 ($ Millions)
Figure 68. Italy Ibandronate Market Size 2024-2029 ($ Millions)
Figure 69. Russia Ibandronate Market Size 2024-2029 ($ Millions)
Figure 70. Spain Ibandronate Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Ibandronate Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Ibandronate Market Size 2024-2029 ($ Millions)
Figure 73. Israel Ibandronate Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Ibandronate Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Ibandronate Market Size 2024-2029 ($ Millions)
Figure 76. Global Ibandronate Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Ibandronate Market Size Market Share Forecast by Application (2024-2029)